Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Advanced Gastrointestinal Cancer in a Phase I/II Trial With Modified Autologous MSC_apceth_101

NCT02008539 is registered in ClinicalTrials.gov with Apceth GmbH & Co. KG as lead sponsor.

NCT NCT02008539
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02008539 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Advanced Gastrointestinal Cancer in a Phase I/II Trial With Modified Autologous MSC_apceth_101
Lead sponsor
Apceth GmbH & Co. KG
Phase
Phase 1/2
Overall status
Terminated
Start date
October 31, 2013
Completion date
September 7, 2016
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced gastrointestinal cancer